Christopher Murphy
Director of Finance/CFO at THIRD HARMONIC BIO, INC.
Christopher Murphy active positions
| Companies | Position | Start | End |
|---|---|---|---|
| THIRD HARMONIC BIO, INC. | Director of Finance/CFO | 2024-01-03 | - |
Career history of Christopher Murphy
Former positions of Christopher Murphy
| Companies | Position | Start | End |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - | - |
Training of Christopher Murphy
| University of Notre Dame | Undergraduate Degree |
Statistics
International
| United States | 3 |
| Ireland | 2 |
Operational
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| THIRD HARMONIC BIO, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Christopher Murphy
- Experience
